Volume 20, Issue 2, Pages (October 2005)

Slides:



Advertisements
Similar presentations
Volume 32, Issue 1, Pages (October 2008)
Advertisements

Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
Volume 36, Issue 5, Pages (December 2009)
Volume 55, Issue 1, Pages (July 2014)
Kinase-Independent Function of Cyclin E
Volume 41, Issue 5, Pages (March 2011)
PHAPI, CAS, and Hsp70 Promote Apoptosome Formation by Preventing Apaf-1 Aggregation and Enhancing Nucleotide Exchange on Apaf-1  Hyun-Eui Kim, Xuejun.
Hirotaka Matsui, Hiroya Asou, Toshiya Inaba  Molecular Cell 
Autoinhibition of c-Abl
Volume 22, Issue 3, Pages (May 2006)
Angiogenin-Induced tRNA Fragments Inhibit Translation Initiation
Usa1 Functions as a Scaffold of the HRD-Ubiquitin Ligase
Yu-Hsin Chiu, Jennifer Y. Lee, Lewis C. Cantley  Molecular Cell 
NRF2 Is a Major Target of ARF in p53-Independent Tumor Suppression
Monica C. Rodrigo-Brenni, Erik Gutierrez, Ramanujan S. Hegde 
Dimers Probe the Assembly Status of Multimeric Membrane Proteins 
Volume 32, Issue 5, Pages (December 2008)
Volume 4, Issue 6, Pages (December 1999)
Lamp-2a Facilitates MHC Class II Presentation of Cytoplasmic Antigens
The TRAF6 Ubiquitin Ligase and TAK1 Kinase Mediate IKK Activation by BCL10 and MALT1 in T Lymphocytes  Lijun Sun, Li Deng, Chee-Kwee Ea, Zong-Ping Xia,
Nithya Raman, Elisabeth Weir, Stefan Müller  Molecular Cell 
Lipotransin Molecular Cell
Volume 48, Issue 2, Pages (October 2005)
Volume 8, Issue 5, Pages (November 2001)
Volume 18, Issue 4, Pages (May 2005)
SV40 VP2 and VP3 Insertion into ER Membranes Is Controlled by the Capsid Protein VP1: Implications for DNA Translocation out of the ER  Robert Daniels,
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Vanessa Brès, Tomonori Yoshida, Loni Pickle, Katherine A. Jones 
HDAC5, a Key Component in Temporal Regulation of p53-Mediated Transactivation in Response to Genotoxic Stress  Nirmalya Sen, Rajni Kumari, Manika Indrajit.
Sukhyun Kang, Megan D. Warner, Stephen P. Bell  Molecular Cell 
Volume 13, Issue 1, Pages (January 2004)
Per Stehmeier, Stefan Muller  Molecular Cell 
Purification of Human Telomerase Complexes Identifies Factors Involved in Telomerase Biogenesis and Telomere Length Regulation  Dragony Fu, Kathleen Collins 
Volume 85, Issue 7, Pages (June 1996)
c-Src Activates Endonuclease-Mediated mRNA Decay
Volume 91, Issue 4, Pages (November 1997)
Andrei Kuzmichev, Thomas Jenuwein, Paul Tempst, Danny Reinberg 
TopBP1 Activates the ATR-ATRIP Complex
Cellular 5′-3′ mRNA Exonuclease Xrn1 Controls Double-Stranded RNA Accumulation and Anti-Viral Responses  Hannah M. Burgess, Ian Mohr  Cell Host & Microbe 
Volume 50, Issue 6, Pages (June 2013)
Two Functional Modes of a Nuclear Receptor-Recruited Arginine Methyltransferase in Transcriptional Activation  María J. Barrero, Sohail Malik  Molecular.
Volume 11, Issue 12, Pages (June 2001)
Cdc18 Enforces Long-Term Maintenance of the S Phase Checkpoint by Anchoring the Rad3-Rad26 Complex to Chromatin  Damien Hermand, Paul Nurse  Molecular.
Volume 25, Issue 5, Pages (March 2007)
Volume 27, Issue 6, Pages (September 2007)
A Stable Prefusion Intermediate of the Alphavirus Fusion Protein Reveals Critical Features of Class II Membrane Fusion  Claudia Sánchez-San Martín, Hernando.
Lindsey A. Allan, Paul R. Clarke  Molecular Cell 
Centrosome-Associated NDR Kinase Regulates Centrosome Duplication
Volume 61, Issue 2, Pages (January 2016)
Volume 34, Issue 6, Pages (June 2009)
Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation
Volume 16, Issue 16, Pages (August 2006)
Volume 29, Issue 4, Pages (February 2008)
SIRT1 Regulates the Function of the Nijmegen Breakage Syndrome Protein
Volume 4, Issue 4, Pages (October 1999)
Volume 7, Issue 6, Pages (June 2001)
Volume 19, Issue 6, Pages (September 2005)
BiP Acts as a Molecular Ratchet during Posttranslational Transport of Prepro-α Factor across the ER Membrane  Kent E.S Matlack, Benjamin Misselwitz, Kathrin.
Meiotic Inactivation of Xenopus Myt1 by CDK/XRINGO, but Not CDK/Cyclin, via Site- Specific Phosphorylation  E. Josué Ruiz, Tim Hunt, Angel R. Nebreda 
Yuki Okuda-Shimizu, Linda M. Hendershot  Molecular Cell 
Tatiana Soldà, Carmela Galli, Randal J. Kaufman, Maurizio Molinari 
Volume 55, Issue 1, Pages (July 2014)
Volume 23, Issue 2, Pages (August 2005)
Volume 36, Issue 4, Pages (November 2009)
Volume 65, Issue 5, Pages e4 (March 2017)
Volume 91, Issue 4, Pages (November 1997)
Volume 41, Issue 4, Pages (February 2011)
Jörg Hartkamp, Brian Carpenter, Stefan G.E. Roberts  Molecular Cell 
Gα12 and Gα13 Interact with Ser/Thr Protein Phosphatase Type 5 and Stimulate Its Phosphatase Activity  Yoshiaki Yamaguchi, Hironori Katoh, Kazutoshi Mori,
Volume 113, Issue 4, Pages (May 2003)
Presentation transcript:

Volume 20, Issue 2, Pages 289-300 (October 2005) ERp29 Triggers a Conformational Change in Polyomavirus to Stimulate Membrane Binding  Brian Magnuson, Emily K. Rainey, Thomas Benjamin, Mikhail Baryshev, Souren Mkrtchian, Billy Tsai  Molecular Cell  Volume 20, Issue 2, Pages 289-300 (October 2005) DOI: 10.1016/j.molcel.2005.08.034 Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 1 ER Activity Triggers a Conformational Change in Py (A) Py (RA strain) was incubated with a control protein (bovine serum albumin, BSA) or a lumenal extract with or without DTT and/or EGTA followed by trypsin addition. Samples were analyzed by SDS-PAGE and immunoblotted with VP1 antibody. (B) As in (A) except the Py PTA strain was used. (C) As in (A) except a lumenal extract derived from mouse (instead of dog) microsomes was used. (D) Mass-spectrometry demonstrated that a C-terminal tryptic fragment (residues 353–368) in VP1 is absent in VP1b. Thus, the C-terminal arm of VP1 is exposed by ER activity. The position of R352 is highlighted in the existing structure of Py VP1 pentamer (PDB number 1sid) to pinpoint the region of the virus that likely is exposed. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 2 ER Activity Is Heat-Labile and Energy Independent Py (RA) was incubated with BSA, a lumenal extract (with or without heat inactivation), or a cytosolic extract in the presence of DTT/EGTA and ATP (where indicated), followed by trypsin addition. Samples were analyzed as in Figure 1. The lumenal and cytosolic extracts were immunoblotted with antibodies against PDI and Hsp90. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 3 ER Activity Fractionation (A) Based on initial studies, a strategy was developed to identify ER activity, with the expected activity fractionation pattern indicated by solid arrows. (B) (upper) The unbound lumenal proteins from Con A- and DEAE-Sepharose columns were bound to a Q-Sepharose column and eluted with a continuous salt gradient. Activity in each fraction was analyzed as in Figure 1. Fractions (lower) were analyzed for their protein content by reducing SDS-PAGE followed by Coomassie staining. Asterisk (*) indicates the 31 kDa protein and (**) indicates the 29 kDa protein. (C) (left) The 29 and 31 kDa protein bands in fraction 8 were excised and subjected to mass-spectroscopy analysis or N-terminal sequencing, respectively. The 29 kDa protein was identified as ERp29, an ER resident protein, whereas the 31 kDa protein is an uncharacterized ER-resident thioredoxin-containing protein. An antibody (right) against rat ERp29 confirmed the identity of the 29 kDa protein. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 4 ERp29 Triggers the Conformational Change in Py (A) (left) The ability of an ERp29-depleted extract to induce VP1b formation was analyzed as in Figure 1. Samples were also immunoblotted with an antibody against ERp29. (Right) A PDI- and an Ero1-depleted extract were tested for their ability to induce VP1b formation. Samples were also immunoblotted with an antibody against ERp29, PDI, and Ero1 (α/β). (B) As in (A) except Py PTA strain was used in the reaction. (C) (left) Nontransfected and ERp29-transfected 3T6 cell extracts were tested for activity. The levels of ERp29, PDI, ERp57, ERp72, and Bip in the lysates were analyzed by immunoblotting with the appropriate antibodies. (Middle) Bacterial extract containing His-tagged ERp29 was tested for activity. (Right) Purified bacterially expressed ERp29 incubated with or without an ERp29-depleted extract was tested for activity. (D) (left) His-tagged ERp29 NTD and CTD were expressed in bacteria and purified. Asterisk (*) indicates an unidentified protein. (Middle) Py was incubated with BSA, a lumenal extract, the NTD, a lumenal extract containing BSA, or a lumenal extract containing the NTD, and activity was assessed as in Figure 1. (Right) As per the middle panel, except the CTD was used instead of the NTD. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 5 ERp29 Induces Py to Bind to Membranes (A) Py was incubated with BSA or a lumenal extract followed by the addition of biotinylated-liposomes (where indicated) bound to Streptavidin-coated magnetic beads. Samples were transferred to a magnetic apparatus to separate the membrane bound (pellet) from the membrane unbound (SN) fractions. The samples were analyzed by SDS-PAGE followed by immunoblotting with an antibody against VP1. (B) (left) As in (A) except where indicated. Samples were treated with proteinase K. The samples were also immunoblotted with an antibody against VP2/VP3. (Right) Liposomes harboring His-tagged ERp29 were incubated with either BSA or Py and a lumenal extract. Samples were treated with proteinase K and Triton X-100 (where indicated) and immunoblotted with an antibody against the His-epitope. (C) An ERp29-depleted extract was tested for membrane binding activity. (D) A 3T6 cell extract overexpressing ERp29 was compared to a control extract for membrane binding activity. (E) (left) Membrane binding activity of a virus containing only the VP1 protein (VP1-VLP) is compared to a wild-type (WT) Py. (right) The ability of VP1-VLP to generate the VP1b fragment was tested, as in Figure 1. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions

Figure 6 ERp29 Facilitates Py Infection (A) 3T6 cells were incubated with Py for 2 hr, washed, and the cells were harvested or allowed to continue to grow for an additional 46 hr and then harvested. The lysates were probed for the presence of VP1 and tubulin as a loading control. (B) As in (A) except, where indicated, cells were transfected with either an empty vector, a cDNA encoding ERp29 NTDKEEL, or a cDNA encoding HA-tagged calreticulin, prior to infection. An antibody against HA was used to detect the expression of calreticulin. Hsp90 level was used as a loading control. (C) FRTL-5 rat thyrocytes were transfected with either an empty vector or cDNA encoding ERp29 NTDKEEL. The levels of ERp29, NTD (lower), and extracellular thyroglobulin (upper) were assessed by immunoblotting. Molecular Cell 2005 20, 289-300DOI: (10.1016/j.molcel.2005.08.034) Copyright © 2005 Elsevier Inc. Terms and Conditions